Iterum Therapeutics Announces Expiration and Preliminary Results of Rights Offering

NEXT STORY
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
PREV STORY
Hospital Acquired Infections (HAI) Diagnostics Market To Reach USD 5.68 Billion By 2027 | Reports and Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Capricor Therapeutics Announces Key Updates on its Vaccine and Therapeutic Programs for COVID-19

author_avatar
NASDAQ Market News

American Gene Technologies to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

author_avatar
NASDAQ Market News

I-Mab Appoints Gigi Feng as Vice President and Global Head of Corporate Communications

author_avatar
NASDAQ Market News